Interclean Shanghai

Infinite Brain Technologies and ATLATL Innovation Centre Collaborate to Address Brain Health Challenges

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Infinite Brain Technologies and ATLATL Innovation Centre form collaborative partnership to advance brain health technology through AI integration

With this development, Infinite Brain Technologies and ATLATL Innovation Centre have formalised a memorandum of understanding to propel the evolution of brain health technology in conjunction with artificial intelligence.

This partnership with ATLATL, leverages its extensive R&D services and vast bio-tech networks, and IBT work towards the mission of creating cutting-edge AI-powered digital therapeutics. Moreover, this partnership provides effective clinical solutions for individuals battling mental disorders.

IBT specialises in the meticulous development of digital therapeutics tailored to global brain health challenges. This strategic collaboration with ATLATL is poised to pioneer precise digital therapeutics for brain health, leveraging cutting-edge AI technologies.

Recognised for its proficiency in crafting precise digital therapeutics through advanced AI techniques, IBT is honoured to unite with ATLATL to catalyse global innovation in the realm of brain health.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »